November 13, 20268 min readAddiction recovery

What the Research Says About ADHD and Cannabis

No study we found shows cannabis treats ADHD, and cannabis use disorder is more common in men with ADHD. See the research and how to cut back.

Rachel Stein

Last reviewed: October 2026

A worried yellow buddy in glasses sits at the top of a long slide on a green hill, glancing down its warmly glowing first stretch toward a thick grey cloud bank that hides the rest.

Research on ADHD and cannabis shows no proof that cannabis treats ADHD, and people with ADHD have higher rates of cannabis use disorder. The one small trial of a cannabis-based medicine did not hold up after statistical correction, and no study we found tests cannabis together with stimulants.

Most of what follows comes from observational studies, so it shows links, not causes. The sections below say where the evidence stops, and none of it replaces a conversation with your own prescriber.

Does cannabis help ADHD symptoms?

No study we found shows that it does. A 2023 narrative review by Gujska and colleagues in Medical Science Monitor cites an analysis of online posts in which 25% called cannabis effective for ADHD symptoms and 8% called it harmful. Those are opinions, not measurements.

The same review adds that many studies show cannabis can worsen inattention, hyperactivity and impulsivity. It also warns that some of its evidence comes from self-report measures. A 2023 systematic review in Cureus by Dhamija and colleagues (20 articles selected from 136 records) called the evidence base small and the effects of cannabis on ADHD symptoms not thoroughly investigated in earlier research.

So people report that it helps, and no trial confirms it. Before you decide, note how your attention is the next day.

Is there a clinical trial of cannabis medicine for ADHD?

There is one, and it was small. Sarris and colleagues, in a 2020 systematic review in BMC Psychiatry, found a single pilot randomized trial: nabiximols, an oral spray with standardized levels of THC and CBD, in 30 adults with ADHD for 6 weeks. It showed no significant difference on its primary outcomes, cognitive performance and activity level, and it did not impair cognition.

On a secondary measure, the investigator-rated Conners Adult ADHD Rating Scale, hyperactivity and impulsivity scores improved by a nominally significant amount. That result did not meet significance after adjustment for multiple testing. A serious adverse event involving muscular seizures or spasms occurred in the active group. The review's overall verdict across psychiatric disorders was that it is premature to recommend cannabinoid-based interventions.

A larger 2022 meta-analysis in BMC Medicine by Bilbao and Spanagel pooled 152 randomized trials (12,123 participants) across many conditions. ADHD was represented by a single small nabiximols trial, with a standardized mean difference of −0.83 (95% CI −1.58 to −0.09, P = 0.03). That is the single trial's secondary hyperactivity and impulsivity measure, which Sarris and colleagues say did not survive correction for multiple testing. The authors could not grade single-trial indications like ADHD and excluded them from their conclusions. A spray tells us little about smoked cannabis, so bring questions to a clinician.

Why do people with ADHD use cannabis?

The oldest explanation is self-medication. Gujska and colleagues note the theory dates to 1974: people use a substance to ease symptoms they find unpleasant. They also report earlier work showing that people using cannabis as self-medication were more likely to have the combined ADHD subtype.

Other explanations compete. The same review lists high sensation-seeking and impulsiveness, and shared dysregulation in the brain's reward and motivation systems, which our guide to dopamine detox for ADHD covers. Dhamija and colleagues, citing earlier work, say the links between ADHD and cannabis use are essentially explained by shared family environment and genetics rather than causal factors.

None of these explains any one person. If you reach for cannabis to quiet restlessness, handle stress or get to sleep, name which one, because the answer differs for each.

Does marijuana make ADHD worse?

Several studies link cannabis use to worse functioning in ADHD, though none settles cause. Gujska and colleagues report that frequent use produces changes in executive functioning similar to those central to ADHD, and cite findings suggesting that high-THC strains impair executive functioning while high-CBD strains do not. Executive function is central to ADHD, as our piece on executive dysfunction explains.

A 2025 cross-sectional study in the journal Cannabis gathered data on 160 young adults aged 19 to 25 who used cannabis regularly. Inattentive symptoms were directly linked to work or school consequences, self-care problems and blackouts or memory impairment, regardless of how much cannabis people used. Hyperactive and impulsive symptoms were linked to dependence through greater amounts used. Cross-sectional data cannot say which came first, and symptoms were self-reported.

Then there is medication. Carbone and colleagues, in a 2026 Journal of Clinical Medicine study of 67 adults on ADHD medication, found 48 (71.6%) responded. Cannabis use disorder carried lower odds of response (OR about 0.20 to 0.24). The authors call it exploratory, since it was retrospective and small, and it cannot show that cannabis caused a weaker response. If you take ADHD medication and use cannabis, tell your prescriber so they can weigh it when judging how the medication is working.

Related Challenges & Plans

Are people with ADHD more likely to get addicted to cannabis?

Yes, in the studies we reviewed. Vogel and colleagues followed 5,103 young Swiss men, all Army conscripts, for 15 months in a prospective cohort published in Addiction in 2016. The 215 men (4.2%) who screened positive for ADHD were more likely to meet criteria for cannabis use disorder, and the number meeting them was almost three times higher than in men without ADHD. Men with ADHD who had not used cannabis at the start were also more likely to start.

Their use did not escalate over the 15 months. The authors say the results apply only to men and rest on a self-report ADHD screener, not a diagnostic interview, and self-reported use. Gujska and colleagues also report that ADHD affects 34% to 46% of adults seeking treatment for cannabis use disorder, and that cannabis use disorder is generally more common in males than females. The research does not explain why, so count the days you use each week and bring that number to a clinician.

Can you take cannabis with Adderall, Vyvanse or other ADHD stimulants?

The research cannot tell you. Dhamija and colleagues write that the evidence is inconclusive on whether cannabis use has an addictive effect or interactions, whether beneficial or detrimental, and that medication effects alongside cannabis are not thoroughly investigated. We found no study testing the combination directly.

The closest large study asked something else. A 2025 cohort in JAACAP Open followed 1,541 children prescribed a stimulant at age 7 or younger, for a median of 13 years. Combined stimulant and psychosocial treatment made no significant difference in any cannabis use compared with stimulants alone (aOR 0.88, p = .07). That asks whether childhood treatment changes later use, not what happens when you take both at once.

Bring your medication list and your use pattern, how often and how much, in plain numbers, to your prescriber. They know your history and can weigh the combination for you.

Does smoking weed help ADHD sleep?

The research does not show that it does. Sleep is a common reason people give, though. Dhamija and colleagues report that sleep disturbance is a frequent justification for cannabis use among people with ADHD symptoms. They also cite research showing people grow accustomed to the short-term sleep benefit, which encourages more use and raises the risk of cannabis-related problems.

For insomnia in general, Sarris and colleagues found plenty of anecdotal survey evidence but called the evidence for this use very weak and located no randomized trials of cannabinoids for insomnia. That evidence was not specific to ADHD.

If sleep is the real job you hired cannabis for, try these:

Write down the pattern. Note bedtime, use and sleep onset for a week.

Start with the sleep problem itself. Our guide on why you cannot go to bed with ADHD covers the usual causes.

Raise it at your next appointment. A clinician can look at the sleep problem on its own.

Can cannabis use be mistaken for ADHD in an assessment?

It can. Gujska and colleagues report that frequent cannabis use produces neurocognitive changes in executive functioning similar to those central to ADHD. A clinician looking at poor focus may be seeing either condition, or both.

That is a reason to be upfront rather than to hide your use. Tell the clinician how often you use, for how long, and when you last used. A fuller history helps them judge which symptoms were there before you started using.

How do I cut down on cannabis when I have ADHD?

You can. Ahlers and colleagues, in a 2022 Journal of Medical Internet Research secondary analysis of a randomized trial, studied CANreduce 2.0, a 6-week self-guided web program built on motivational interviewing and cognitive behavioral therapy. They compared 94 adults who screened positive for ADHD with 273 who did not, all using cannabis weekly or more, at 3 months.

Both groups cut their use significantly, and adults who screened positive for ADHD cut back about as much as those who did not. Cannabis days in the previous 30 dropped by a mean of 11.53 in the ADHD-positive group and 8.53 in the other, and the change did not differ significantly between groups. Adults who screened positive were less likely to complete the consumption diary (P = .02). The analysis had no control arm, a short follow-up and a self-report ADHD screener, and the ADHD group began with more cannabis days.

Try this:

Track it in the smallest way you will keep. One tally mark per use, on your phone or a card.

Pick one use to move. Choose the use with the clearest reason behind it, and plan a different move for that moment. Pair it with a skill from CBT for adult ADHD.

Add a person. A buddy on GetMotivated.ai can check in on how you are doing, so the plan does not depend on your memory alone.

Expect slips. Our guide to why you keep relapsing explains the brain side.

If cutting back stalls, ask a clinician about a structured program. Take ten minutes today to write the days you used this past week and what you hoped each use would do, then bring that page to your next appointment.

Next time you search, our newest guide shows up.

Sources

Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indicationsResearch
Bilbao A & Spanagel R
BackgroundMedical cannabinoids differ in their pharmacology and may have different treatment effects. We aimed to conduct a pharmacology-based systematic review (SR) and meta-analyses of medical cannabinoids for efficacy, retention and adverse events.MethodsWe systematically reviewed (registered at PROSPERO: CRD42021229932) eight databases for randomized controlled trials (RCTs) of dronabinol, nabilone, cannabidiol and nabiximols for chronic pain, spasticity, nausea /vomiting, appetite, ALS, irritable bowel syndrome, MS, Chorea Huntington, epilepsy, dystonia, Parkinsonism, glaucoma, ADHD, anorexia nervosa, anxiety, dementia, depression, schizophrenia, PTSD, sleeping disorders, SUD and Tourette. Main outcomes and measures included patient-relevant/disease-specific outcomes, retention and adverse events. Data were calculated as standardized mean difference (SMD) and ORs with confidence int
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic reviewResearch
Sarris J et al.
BackgroundMedicinal cannabis has received increased research attention over recent years due to loosening global regulatory changes. Medicinal cannabis has been reported to have potential efficacy in reducing pain, muscle spasticity, chemotherapy-induced nausea and vomiting, and intractable childhood epilepsy. Yet its potential application in the field of psychiatry is lesser known.MethodsThe first clinically-focused systematic review on the emerging medical application of cannabis across all major psychiatric disorders was conducted. Current evidence regarding whole plant formulations and plant-derived cannabinoid isolates in mood, anxiety, sleep, psychotic disorders and attention deficit/hyperactivity disorder (ADHD) is discussed; while also detailing clinical prescription considerations (including pharmacogenomics), occupational and public health elements, and future research recommen
Exploring the Link Between Attention-Deficit Hyperactivity Disorder and Cannabis Use Disorders: A ReviewResearch
Gujska JH et al.
Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder in children and adults. In the substance use disorders (SUDs) population, ADHD prevalence reaches 23.1%, leading to more severe substance abuse progression and reduced treatment effectiveness. Cannabis is the most common illicit drug used among the ADHD population. The increasing popularity of medical marijuana (MM) has raised concerns about its potential impact on neurocognitive functions, particularly in adolescents. Persistent cannabis use can cause permanent changes in brain structures and circuits. This review aims to overview the comorbidity of ADHD and SUDs, focusing on cannabis use disorders. Theoretical models of the etiologies of ADHD and SUDs were investigated to establish a framework for analyzing their underlying neurocognitive mechanisms. The reward and motivational brain circuitries
Evaluation of Efficacy of Cannabis Use in Patients With Attention Deficit Hyperactivity Disorder: A Systematic ReviewResearch
Dhamija D et al.
Cannabis is frequently used by people who self-medicate for the signs of mental health conditions. Attention-deficit/hyperactivity disorder (ADHD), a neurodevelopmental illness, has been linked to increased cannabis use. However, compared to other mental disorders, cannabis use by people with ADHD has received much less research. The main goal of this systematic review was to understand the nature of the relationships between cannabis use and ADHD symptoms. We used Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to conduct the systematic review. We included papers published within the previous ten years from online searches on PubMed, PubMed Central (PMC), Google Scholar, and ScienceDirect until January 1st, 2023. The inclusion-exclusion criteria led to the initial selection of 136 studies. We selected twenty research articles after screening and as
Cannabis Use in Adults Who Screen Positive for Attention Deficit/Hyperactivity Disorder: CANreduce 2.0 Randomized Controlled Trial Subgroup AnalysisResearch
Ahlers J et al.
BackgroundPrevalence rates for lifetime cannabis use and cannabis use disorder are much higher in people with attention deficit/hyperactivity disorder than in those without. CANreduce 2.0 is an intervention that is generally effective at reducing cannabis use in cannabis misusers. This self-guided web-based intervention (6-week duration) consists of modules grounded in motivational interviewing and cognitive behavioral therapy.ObjectiveWe aimed to evaluate whether the CANreduce 2.0 intervention affects cannabis use patterns and symptom severity in adults who screen positive for attention deficit/hyperactivity disorder more than in those who do not.MethodsWe performed a secondary analysis of data from a previous study with the inclusion criterion of cannabis use at least once weekly over the last 30 days. Adults with and without attention deficit/hyperactivity disorder (based on the Adult
Understanding the Relationships between ADHD Symptoms and Cannabis-Related Consequences among Young AdultsResearch
Minister C et al.
ObjectiveThe link between attention-deficit/hyperactivity disorder (ADHD) and cannabis-related problems is well documented, though research has primarily focused on cannabis use disorder (CUD) or cannabis consequences in aggregate. This study examined how inattentive (IN) versus hyperactive/impulsive (HI) ADHD symptoms relate to CUD symptoms as well as distinct domains of cannabis consequences (social-interpersonal consequences, impaired control, negative self-perception, self-care, risk behaviors, academic/occupational consequences, physical dependence, and blackout use) in young adults. Total amount of cannabis flower used over the past 90 days was explored as a potential mediator of these associations.MethodYoung adults (N = 160; 41% male; ages 19-25, M = 22, SD = 2.06) with a history of regular cannabis use completed self-report measures of ADHD symptoms and cannabis consequences. Pa
Is attention deficit/hyperactivity disorder among men associated with initiation or escalation of substance use at 15-month follow-up? A longitudinal study involving young Swiss menResearch
Vogel T et al.
Background and aimsYoung adults with attention deficit/hyperactivity disorder (ADHD) show higher substance use disorder (SUD) prevalence relative to non-ADHD controls; few longitudinal studies have examined the course of substance use with reference to conduct disorder (CD). We compared initiation and escalation of substance use at 15-month follow-up in men screened positive or negative for ADHD (ADHD(+) versus ADHD(-) ), controlling for CD presence in early adolescence.DesignParticipants were recruited during August 2010 and November 2011 from the census of all young men who have to pass mandatory army conscription from three of six Swiss Army recruitment centres. A two-wave data collection was performed via questionnaires at baseline and 15-month follow-up as a part of the longitudinal Cohort Study on Substance Use Risk Factors.SettingRecruitment centres in Lausanne, Windisch and Mels,
Factors Associated with Reduced Clinical Response in Adult ADHD: The Role of Alcohol and Cannabis Use Disorders and Autism Spectrum DisorderResearch
Carbone MG et al.
Background: Attention-Deficit/Hyperactivity Disorder (ADHD) in adulthood is frequently associated with complex psychiatric comorbidity, including high rates of Substance Use Disorders (SUDs), which may influence treatment outcomes. Although pharmacological treatments are effective for core ADHD symptoms, real-world response remains heterogeneous, and the contribution of specific substance-related and neurodevelopmental factors to treatment response is not fully understood. Methods: This retrospective observational study examined a real-world cohort of 67 adults with ADHD treated pharmacologically in a specialized outpatient setting. ADHD was diagnosed according to DSM-5-TR criteria using the Diagnostic Interview for ADHD in Adults (DIVA-5). Autism spectrum disorder (ASD) was recorded based on documented pre-existing specialist diagnoses and confirmed clinically at baseline. Psychiatric c
Does Combined Stimulant and Psychosocial Treatment in Childhood Attention-Deficit/Hyperactivity Disorder Protect Against Future Substance Use?Research
Bommersbach TJ et al.
ObjectiveAttention-deficit/hyperactivity disorder (ADHD) is a risk factor for future substance use. Stimulant medication has largely failed to demonstrate protection against future substance use, but no studies have assessed whether combined stimulant and psychosocial treatment reduces future substance use compared with stimulants alone.MethodThis retrospective study used data from the Rochester Epidemiology Project, a medical records repository in Olmsted County, Minnesota, to identify 1,541 children ≤7 years old who were prescribed a stimulant for ADHD between 2003 and 2019. Of children, 40% (n = 628) also received psychosocial treatment. Data on substance use after age 10 were gathered from the medical record until 2023, comprising up to 17 years of follow-up. Logistic regression compared substance use outcomes between the 2 treatment groups, and multivariable models identified childh

Topics

AI-ready summary

The one randomized trial of a cannabis-based medicine for ADHD, in 30 adults, was null on its main outcomes, and its hyperactivity gain did not survive correction for multiple testing. ADHD is linked to higher rates of cannabis use disorder, including almost three times the rate in a cohort of 5,103 Swiss men. No study we found tests cannabis combined with stimulants, and an online program cut cannabis use about as much in adults who screened positive for ADHD as in those who did not.

Key takeaways

  • No study we found shows cannabis treats ADHD. The only trial, in 30 adults on a spray, was null on its main outcomes, and its hyperactivity gain did not survive correction for multiple testing.
  • In 5,103 Swiss men, cannabis use disorder was almost three times as common among the 215 who screened positive for ADHD.
  • No study we found tests cannabis alongside stimulant medication, so ask your prescriber rather than assuming it is fine.
  • Heavy cannabis use can look like ADHD in an assessment, so tell the clinician how often you use.
  • In a secondary analysis of a randomized trial, adults who screened positive for ADHD cut cannabis use about as much as adults who did not.

FAQs

Does cannabis help ADHD symptoms?

No study we found shows that it does. The one small trial of a cannabis-based spray, in 30 adults over 6 weeks, missed its main goal, and its hyperactivity result did not hold after correction for multiple testing, according to Sarris and colleagues.

Is weed good or bad for ADHD?

No study we found shows a benefit. A narrative review by Gujska and colleagues reports that many studies show cannabis can worsen inattention, hyperactivity and impulsivity, though some of that evidence rests on self-report.

Are people with ADHD more likely to get addicted to cannabis?

The studies point that way. In a cohort of 5,103 young Swiss men, Vogel and colleagues found cannabis use disorder was almost three times as common among the 215 men who screened positive for ADHD.

Can you take cannabis with Adderall, Vyvanse or other ADHD stimulants?

No study we found tests cannabis taken alongside stimulants, so the research cannot say whether it is safe. A 2023 systematic review calls the evidence on cannabis effects and interactions in general inconclusive, so tell your prescriber what you use.

Does smoking weed help ADHD sleep?

Sleep trouble is a common reason people with ADHD give for using cannabis, but a 2023 review also reports that people get used to its short-term sleep effect and use more. Sarris and colleagues located no randomized trials of cannabinoids for insomnia in their 2020 review.

How do I cut down on cannabis when I have ADHD?

A 6-week online program using motivational interviewing and CBT cut cannabis days about as much in 94 adults who screened positive for ADHD as in 273 who did not. Start by tracking your use and ask a clinician about a structured plan.

Related Challenges & Plans

Keep reading